| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504720A1 Chimeric oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504701A1 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | CA2504554A1 2'-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | CA2503621A1 Methods and compositions for diagnosing dysplasia |
| 05/26/2004 | EP1421379A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 05/21/2004 | WO2004042057A1 Method of detecting gene mutation |
| 05/21/2004 | WO2004042030A2 Displacement sandwich immuno-pcr |
| 05/21/2004 | WO2004042023A2 Stem cell libraries |
| 05/21/2004 | WO2004042013A2 Identification of diet-regulated disease-associated genes |
| 05/21/2004 | WO2004042012A2 Process for concentration of macromolecules |
| 05/21/2004 | WO2004042004A2 Mouse model for autoimmune disorders |
| 05/21/2004 | WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | WO2004041996A2 System for and method of positioning cells and determining cellular activity thereof |
| 05/21/2004 | WO2004031351A9 Microarrays having multiple oligonucleotides in single array features |
| 05/21/2004 | WO2004029211A3 Frozen spermatozoa compositions and uses thereof |
| 05/21/2004 | WO2004027027A3 Method of inhibiting choroidal neovascularization |
| 05/21/2004 | CA2506654A1 Method of detecting gene mutation |
| 05/21/2004 | CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | CA2503811A1 Identification of diet-regulated disease-associated genes |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097593 Compounds for treatment of inflammation, diabetes and related disorders |
| 05/20/2004 | US20040096970 Producing synchronized population of pine somatic embryos for generation and propagation of trees possessing rapid growth rates and improved wood quality; tissue engineering |
| 05/20/2004 | US20040096870 Methods of detecting sequence differences |
| 05/20/2004 | US20040096832 Method for cloning of a rare, specifically mutated cell |
| 05/20/2004 | US20040096827 Method for search based character optimization |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | DE10251918A1 Inheritable integration of DNA into germ-line invertebrate cells, useful for large-scale production of transgenic insects, includes post-transformational removal of mobilizable elements to increase stability |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/13/2004 | WO2004039953A2 Array oligomer synthesis and use. |
| 05/13/2004 | WO2004039952A2 Methods of use for novel human polypeptides encoded by polynucleotides |
| 05/13/2004 | WO2004020602A3 Terminal phosphate blocked nucleoside polyphosphates |
| 05/13/2004 | WO2003072747A3 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | CA2222581C Oligonucleotide tags for sorting and identification |
| 05/06/2004 | WO2004038005A2 Methods of identifying reduced internalization transmembrane receptor agonists |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037996A2 Evaluation of breast cancer states and outcomes using gene expression profiles |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037192A2 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 05/06/2004 | WO2003106631A3 Methods and compositions relating to labeled rna molecules that reduce gene expression |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087533 Antisense compounds, methods and compositions for treating MMP-12 related inflammatory disorders |
| 05/06/2004 | US20040086508 Administering to the patient an effective amount of an antibody that specifically binds interferon gamma and an antibody that specifically binds tumor necrosis factor alpha |
| 05/06/2004 | EP1415001A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | CA2501677A1 Treatment of diabetes |
| 05/05/2004 | CN1148453C Glyphosate resistant transgenic plants |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 04/29/2004 | WO2004035748A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/29/2004 | WO2004035744A2 Methods for purifying radiolabelled compounds |
| 04/29/2004 | WO2004035732A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 04/29/2004 | WO2004035730A2 Crystals and structures of atp phosphoribosyltransferase |
| 04/29/2004 | WO2003104392A9 Improved reagents and methods for producing parvoviruses |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040081993 Quantification of gene expression |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081958 Identification and use of molecular markers indicating cellular reprogramming |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | CA2502250A1 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells |
| 04/28/2004 | EP1412750A2 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412376A2 Compositions and methods for labeling oligonucleotides |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/22/2004 | WO2004033669A2 Methods of manipulating nucleic acids |
| 04/22/2004 | WO2004033649A2 High throughput multiplex dna sequence amplifications |
| 04/22/2004 | WO2004033646A2 Process for the biological production of 1,3-propanediol with high yield |
| 04/22/2004 | WO2004033641A2 Gene expression profiling of bladder cancer |
| 04/22/2004 | WO2004033640A2 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/22/2004 | WO2004033629A2 Reverse transcription on microarrays |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003014308A9 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040076988 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/22/2004 | US20040076633 Genetic vaccines comprising a 1H-imidazo(4,5-c)- 4-amine derivative as an adjuvant, for increasing immune responses in a mammal to the encoded antigen |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | CA2501574A1 Process for the biological production of 1,3-propanediol with high yield |
| 04/22/2004 | CA2501078A1 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/21/2004 | EP1410301A2 System for identifying and analyzing expression of are-containing genes |
| 04/21/2004 | EP1409712A2 Microfermentor device and cell based screening method |
| 04/21/2004 | CN1146668C Oligonucleotide tags for sorting and identification |
| 04/15/2004 | WO2004031366A2 Manufacturing method and readout system for biopolymer arrays |
| 04/15/2004 | WO2004031360A2 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | WO2004031351A2 Microarrays having multiple oligonucleotides in single array features |
| 04/15/2004 | WO2003102144A3 Compositions and methods of use for an ephrin rreceptor |
| 04/15/2004 | WO2003078570A3 Multiple controls for molecular genetic analyses |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040072150 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid |
| 04/15/2004 | US20040071712 Modified peptides as therapeutic agents |
| 04/15/2004 | US20040071693 Humanised antibodies |